Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Biomarkers of brain Aβ amyloid deposition can be measured either by cerebrospinal fluid Aβ42 or Pittsburgh compound B positron emission tomography imaging. Our objective was to evaluate the ability of Aβ load and neurodegenerative atrophy on magnetic resonance imaging to predict shorter time-to-prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Jack, Clifford R., Wiste, Heather J., Vemuri, Prashanthi, Weigand, Stephen D., Senjem, Matthew L., Zeng, Guang, Bernstein, Matt A., Gunter, Jeffrey L., Pankratz, Vernon S., Aisen, Paul S., Weiner, Michael W., Petersen, Ronald C., Shaw, Leslie M., Trojanowski, John Q., Knopman, David S.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965425/
https://www.ncbi.nlm.nih.gov/pubmed/20935035
http://dx.doi.org/10.1093/brain/awq277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965425/
https://www.ncbi.nlm.nih.gov/pubmed/20935035
http://dx.doi.org/10.1093/brain/awq277

Ejemplares similares